Interv Akut Kardiol. 2022;21(3):127-131 | DOI: 10.36290/kar.2022.026

Catheterisation Interventions in Patients with Total Cavopulmonary Connection

Ondřej Materna, Petr Tax, Oleg Reich, Michal Jičínský, Denisa Jičínská, Karel Koubský, Václav Chaloupecký, Jan Janoušek
Dětské kardiocentrum 2. lékařské fakulty Univerzity Karlovy v Praze a Fakultní nemocnice v Motole, Praha

Background: A small proportion of congenital heart disease cases are united under the diagnosis of a functionally single ventricle. The only management strategy for this group of patients is a series of palliative surgical procedures creating a unique situation of the so-called Fontan circulation. Currently, total cavopulmonary connection (TCPC) is the target intervention in which the superior vena cava is connected directly to the pulmonary artery branch and the inferior vena cava via a valveless intracardiac or extracardiac conduit. The heart is excluded from the pulmonary circulation and the functionally single ventricle is connected only to the systemic circulation.

Patients and methods: We aimed to analyse the number of cardiac surgical and catheterisation procedures in a population of patients with TCPC (N = 407) treated in a single paediatric centre covering the whole region of the Czech Republic.

Results: The 10-year and 20-year survival probability rates in our study group were 96% and 92%, respectively. A total of 1,128 cardiac surgical procedures, 299 catheterisation procedures, and 738 diagnostic catheterisations were performed.

Conclusion: Overall, long-term survival in the population of TCPC patients in the Czech Republic is favourable. However, this group of patients requires a high number of repeated cardiac interventions.

Keywords: congenital heart disease, functionally single ventricle, total cavopulmonary connection, catheterisation intervention.

Received: June 27, 2022; Revised: October 21, 2022; Accepted: October 24, 2022; Published: November 21, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Materna O, Tax P, Reich O, Jičínský M, Jičínská D, Koubský K, et al.. Catheterisation Interventions in Patients with Total Cavopulmonary Connection. Interv Akut Kardiol. 2022;21(3):127-131. doi: 10.36290/kar.2022.026.
Download citation

References

  1. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971;26(3):240-8. Go to original source... Go to PubMed...
  2. Gewillig M, Brown SC. The Fontan circulation after 45 years: Update in physiology. Heart. 2016;102(14):1081-6. Go to original source... Go to PubMed...
  3. Marcelletti C, Corno A, Giannico S, et al. Inferior vena cava­‑pulmonary artery extracardiac conduit. A new form of right heart bypass. J Thorac Cardiovasc Surg. 1990;100(2):228-32. Go to original source...
  4. McGovern E, Alsaied T, Szugye N, et al. The Fontan Pathway: Change in Dimension and Catheter­‑Based Intervention over Time. Pediatr Cardiol. 2021;42(8):1740-8. Go to original source... Go to PubMed...
  5. De Leval MR, Kilner P, Gewillig M, et al. Total cavopulmonary connection: A logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience. J Thorac Cardiovasc Surg. 1988;96(5):682-95. Go to original source...
  6. Fisher DJ, Geva T, Feltes TF, et al. Lifelong management of patients with a single functional ventricle: A protocol. Texas Hear Inst J. 1995;22(4):284-95.
  7. Hadjicosta E, Franklin R, Seale A, et al. Cohort study of intervened functionally univentricular heart in England and Wales (2000-2018). Heart. 2022;108(13):1046-54. Go to original source... Go to PubMed...
  8. Materna O, Illinger V, Jičínská D, et al. Influence of fenestration on long­‑term Fontan survival. Cardiol Young. 2021;31:1-6.
  9. Poterucha JT, Johnson JN, Taggart NW, et al. Embolization of Veno­‑venous Collaterals after the Fontan Operation Is Associated with Decreased Survival. Congenit Heart, DiS. 2015;10(5):E230-6. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.